NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
NanoMosaic has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
NanoMosaic's investors include Insight Partners, RA Capital Management, TIME BioVentures, Pura Vida Investments, TigerGene.
NanoMosaic is headquartered in Waltham, United States.
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
NanoMosaic is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NanoMosaic — Funding & Investors." VCBacked, November 24, 2025, https://www.vcbacked.co/company/nanomosaic. Accessed July 20, 2026.
VCBacked. (2025). NanoMosaic — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/nanomosaic
{{cite web |title=NanoMosaic — Funding & Investors |url=https://www.vcbacked.co/company/nanomosaic |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated